IP Library Granted Patent US 11,815,745
Granted Patent B2
US 11,815,745 · App. 17/969,824 · Granted Nov 14, 2023

Method and apparatus for limiting growth of eye length

Inventors: Jay Neitz (Seattle, WA); Maureen Neitz (Seattle, WA)
Assignee: The Medical College of Wisconsin, Inc.
G02C7/04A61K9/0048G02C7/02G02C7/061G02C7/10G02C7/16A61B3/1005A61B5/107G02C2202/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,815,745
App. No.
17/969,824
Granted
Nov 14, 2023
Kind
B2
Abstract

Certain embodiments of the present invention are directed to therapeutic intervention in patients with eye-length-related disorders to prevent, ameliorate, or reverse the effects of the eye-length-related disorders. Embodiments of the present invention include methods for early recognition of patients with eye-length-related disorders, therapeutic methods for inhibiting further degradation of vision in patients with eye-length-related disorders, reversing, when possible, eye-length-related disorders, and preventing eye-length-related disorders. Additional embodiments of the present invention are directed to particular devices used in therapeutic intervention in patients with eye-length-related disorders.

Claims (28)

1 . An ophthalmic lens, comprising:

a first area comprising a plurality of elements selected from the group consisting of:

(i) bumps on a surface of the lens;

(ii) depressions on the surface of the lens;

(iii) translucent inclusions in a lens material; and

(iv) transparent inclusions in the lens material, the transparent inclusions having a refractive index different from that of the lens material,

wherein the elements are dot-shaped and the ophthalmic lens is configured to introduce higher-order aberrations into images formed in light that has passed through the ophthalmic lens.

2 . The ophthalmic lens of claim 1 , wherein the ophthalmic lens is configured to introduce the higher order aberrations causing blurring in a peripheral visual field viewed through the ophthalmic lens.

3 . The ophthalmic lens of claim 2 , wherein the ophthalmic lens is configured to provide a central visual field in focus.

4 . The ophthalmic lens of claim 1 , wherein the dot-shaped elements are configured to scatter incident light.

5 . The ophthalmic lens of claim 1 , wherein the dot-shaped elements have a dot density in a range between 0 dots per mm 2 and 8 dots per mm 2 in the first area.

6 . The ophthalmic lens of claim 1 , wherein the first area corresponds to a peripheral visual field observed through the ophthalmic lens.

7 . The ophthalmic lens of claim 1 , further comprising a second area free of the elements.

8 . The ophthalmic lens of claim 7 , wherein the ophthalmic lens is configured to reduce a visual acuity from 20/20 when a line of sight passes through the second area to about 20/25 when the line of sight passes through the first area.

9 . The ophthalmic lens of claim 7 , wherein the first area surrounds the second area.

10 . The ophthalmic lens of claim 1 , further comprising a spectral optical filter.

11 . Eyeglasses comprising the ophthalmic lens of claim 1 .

12 . The eyeglasses of claim 11 , wherein the ophthalmic lens is a first ophthalmic lens and the eyeglasses further comprise a second ophthalmic lens different from the first ophthalmic lens.

13 . The eyeglasses of claim 11 , wherein the ophthalmic lens is a first ophthalmic lens and the eyeglasses further comprise a second ophthalmic lens, the second ophthalmic lens comprises a first area of the second lens comprising a plurality of elements selected from the group consisting of:

(i) bumps on a surface of the lens;

(ii) depressions on the surface of the lens;

(iii) translucent inclusions in a lens material; and

(iv) transparent inclusions in the lens material, the transparent inclusions having a refractive index different from that of the lens material,

wherein the elements of the second ophthalmic lens are dot-shaped.

14 . The eyeglasses of claim 11 , wherein the ophthalmic lens is a first ophthalmic lens and the eyeglasses further comprise a second ophthalmic lens configured to introduce higher-order aberrations into images formed in light that has passed through the second ophthalmic lens.

15 . An article, comprising:

an ophthalmic lens; and

a film applied to a surface of the ophthalmic lens, the film comprising particles that scatter incident light, an amount of scatter varying across the ophthalmic lens so that the article comprises a clear area surrounded by a light-scattering area.

Assignments (2)
CONFIRMATORY LICENSE Recorded Aug 16, 2023
From: MEDICAL COLLEGE OF WISCONSIN
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 064605/0832 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 20, 2022
From: NEITZ, JAY; NEITZ, MAUREEN
To: THE MEDICAL COLLEGE OF WISCONSIN, INC.
Reel/Frame 061480/0218 →
Continuity (7)
Continuation 17352570 · Jun 21, 2021
Continuation 17008167 · Aug 31, 2020
Continuation 16385810 · Apr 16, 2019
Continuation 15625222 · Jun 16, 2017
Continuation 13141161 · Sep 12, 2011
Provisional Application 61139938 · Dec 22, 2008
Related Publication 20230137646A1 · May 4, 2023
Cited By (1)
US 12,699,283